Evidence map›Paper›PMID 39220611›Full record

ArticlePreventive medicine reports2024

Correlates of intention-to-attend and confirmed cervical screening attendance during the COVID-19 pandemic in Australia: Findings from Compass-PLUS, a prospective cohort study.

Louiza S Velentzis, Sam Egger, Jo Waller, Chloe J Jennett, Julia M L Brotherton, Megan A Smith, Deborah Bateson, Caitlin Rogers, Amy Pagotto, Rachel Skinner and 4 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Preventive medicine reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328872 (Compass - Randomized Controlled Trial of 5-yearly Cervical Screening With Primary HPV Testing Versus Cervical Screening With 2.5-yearly Liquid Based Cytology Testing, in HPV-Unvaccinated and HPV-Vaccinated Women in Australia), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328872 naactive not recruitingnot on this map

Compass - Randomized Controlled Trial of 5-yearly Cervical Screening With Primary HPV Testing Versus Cervical Screening With 2.5-yearly Liquid Based Cytology Testing, in HPV-Unvaccinated and HPV-Vaccinated Women in Australia

TypeinterventionalSponsorVCS FoundationRan2015 to 2037Enrolled76,181ConditionsCancer of the Cervix, Cervical Intraepithelial NeoplasiaArmsMolecular testing for HPV, Liquid Based Cytology
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Louiza S VelentzisThe Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Australia.
Sam EggerThe Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Australia.
Jo WallerWolfson Institute of Population Health, Queen Mary University of London, UK.
Chloe J JennettThe Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Australia.
Julia M L BrothertonMelbourne School of Population and Global Health, University of Melbourne, Victoria, Australia.
Megan A SmithThe Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Australia.
Deborah BatesonThe Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Australia.
Caitlin RogersThe Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Australia.
Amy PagottoThe Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Australia.
Rachel SkinnerChildren's Hospital Westmead Clinical School, University of Sydney, NSW, Australia.
Natalie TaylorSchool of Population Health, University of New South Wales, NSW, Australia.
Rhiannon EdgeThe Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Australia.
Marion SavilleAustralian Centre for the Prevention of Cervical Cancer, Carlton South, Victoria, Australia.
Karen CanfellThe Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The coronavirus pandemic impacted health-seeking behaviour and access to primary care in Australia. We investigated factors associated with intention-to-attend and attendance of cervical screening during the pandemic, mainly in Victoria, Australia. Methods: We used questionnaire and attendance data (Aug 2020-Nov 2022) from Compass-PLUS, a sub-study of the Compass randomized-controlled trial of Human Papillomavirus-based vs cytology-based screening. Data was restricted to the HPV-screening arm for comparability to the national program. We investigated associations overall and for younger (25-39 years) and older (≥40 years) cohorts, between intention-to-attend/attendance, and socio-demographics, anxiety-related scores, and agreement with beliefs about screening during the pandemic (e.g. importance of screening, increased workload, working from home, risk of infection). Results: Among 2,226 participants, positive intention to attend screening was more likely among those with a family history of cancer (p = 0.030) or living outside major cities (p = 0.024). Increased attendance was associated with increasing age (p < 0.001), prior regular cervical screening history [adjusted relative risk (aRR) for 2 screens in 6 years vs none: 1.23 (95 %CI 1.09,1.40); p < 0.001], and part-time employment or retirement compared to full-time employment [aRR:1.08 (1.02,1.14); aRR:1.12 (1.03, 1.22); respectively]. Lower attendance was related to increased agreement with statements indicating screening de-prioritisation (p-trend < 0.05) and higher recent anxiety, specifically in the older cohort (p-trend = 0.002). Conclusions: Reduced priority of screening and heightened recent anxiety may partly explain indications of lower-than-expected cervical screening rates during the pandemic. It is important that catch-up of missed HPV screens is performed to prevent a possible increase in cancer diagnoses in the long term.

Indexed as

AnxietyBehavioursCOVID-19DemographyEarly detection of cancerIntentionPapillomavirus infectionsUterine cervical neoplasms

Identifiers

PMID39220611
PMCPMC11365377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.